massive buy recommendation, page-298

Et-al Dont think I want to see Ridgeback blink at this point in time. Could be nasty. IMO the (significant) # shares issued means we basically have 2 groups of players - the top patient investors are focused on the science, management and the testing - not so much the price at this point in time. The rest of us are basically all in a sandpit with a couple of bullies. At this point in time we have 2 of the 3 magic ingredients (people and product) pretty much locked in h/ever still need to show where/when the profitability will kick in. Once that is clear then it really will be game on - IMO.